Literature DB >> 7259330

Cellular phagocytic studies in rheumatoid arthritis patients treated with levamisole.

K M Wynne, P A Dieppe, J Scott, E C Huskisson.   

Abstract

A simple method is described which allows sequential monitoring of the endocytic activity of blood and synovial fluid cells from rheumatoid arthritis patients undergoing therapy with levamisole. Evidence of immediate (24 hours) and long-term (5-7 weeks) cellular phagocytic enhancement is presented.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7259330      PMCID： PMC1000733          DOI： 10.1136/ard.40.4.382

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  15 in total

1.  Graphic representation of pain.

Authors:  J Scott; E C Huskisson
Journal:  Pain       Date:  1976-06       Impact factor: 6.961

2.  Effects of levamisole on human monocyte function and immunoprotein receptors.

Authors:  M E Schmidt; S D Douglas
Journal:  Clin Immunol Immunopathol       Date:  1976-11

3.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

4.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

5.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

6.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

7.  [The effect of treatment on circulating immune complexes in rheumatoid arthritis (author's transl)].

Authors:  M Rosenthal; U Graf; W Müller
Journal:  Dtsch Med Wochenschr       Date:  1977-03-25       Impact factor: 0.628

8.  Concentrations of levamisole required for enhanced proliferation of human lymphocytes and phagocytosis by macrophages.

Authors:  M S Al-Ibrahim; R S Holzman; H S Lawrence
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

9.  Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.

Authors:  U E Nydegger; R H Zubler; R Gabay; G Joliat; C H Karagevrekis; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Selective phagocytic paralysis induced by immobilized immune complexes.

Authors:  M Rabinovitch; R E Manejias; V Nussenzweig
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307
View more
  4 in total

1.  The influence of synovial fibroblasts on the phagocytosis of Staphylococcus by polymorphonuclear cells.

Authors:  D van Riessen; M R Daha; T J Smeets; F C Breedveld
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Enhanced bacterial phagocytosis by peripheral blood monocytes in rheumatoid arthritis.

Authors:  M M Steven; S E Lennie; R D Sturrock; C G Gemmell
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

3.  Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.

Authors:  Marcelo Bogliolo Piancastelli de Siqueira; Licia Maria Henrique da Mota; Shirley Claudino Pereira Couto; Maria Imaculada Muniz-Junqueira
Journal:  BMC Musculoskelet Disord       Date:  2015-06-30       Impact factor: 2.362

4.  Ten weeks of high-intensity interval walk training is associated with reduced disease activity and improved innate immune function in older adults with rheumatoid arthritis: a pilot study.

Authors:  David B Bartlett; Leslie H Willis; Cris A Slentz; Andrew Hoselton; Leslie Kelly; Janet L Huebner; Virginia B Kraus; Jennifer Moss; Michael J Muehlbauer; Guillaume Spielmann; William E Kraus; Janet M Lord; Kim M Huffman
Journal:  Arthritis Res Ther       Date:  2018-06-14       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.